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Abstract  
Background: Evidence of benefit for telehealth for chronic conditions is mixed. Two linked 
randomised controlled trials tested The Healthlines Service for two chronic conditions: depression 
and high risk of cardiovascular disease (CVD). This new telehealth service consisted of regular 
telephone calls from non-clinical, trained health advisers who followed standardised scripts 
generated by interactive software. Advisors facilitated self-management by supporting participants 
to use online resources and helped to optimise medication, improve treatment adherence and 
encourage healthier lifestyles.  Participants were recruited from primary care. The trials identified 
moderate (for depression) or partial (for CVD risk ) effectiveness of the Healthlines Service. 
Objective: An embedded qualitative study was undertaken to help explain the results of the two 
trials by exploring mechanisms of action, context, and implementation of the intervention. 
Methods: Qualitative interview study of 21 staff providing usual healthcare or involved in the 
intervention and 24 patients receiving the intervention.  
Results: Interviewees described improved outcomes in some patients which they attributed to the 
intervention, describing how components of the model on which the intervention was based helped 
to achieve benefits. Implementation of the intervention occurred largely as planned. However, 
contextual issues in patients’ lives and some problems with implementation may have reduced the 
size of effect of the intervention. For depression, patients’ lives and preferences affected 
engagement with the intervention: these largely working-age patients had busy and complex lives 
which affected their ability to engage, and some patients preferred a therapist-based approach to 
the cognitive behavioural therapy on offer. For CVD risk, patients’ motivations adversely affected the 
intervention whereby some patients joined the trial for general health improvement or from 
altruism, rather than motivation to make lifestyle changes to address their specific risk factors. 
Implementation was not optimal in the early part of the CVD risk trial due to technical difficulties 
and the need to adapt the intervention for use in practice. For both conditions, enthusiastic and 
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motivated staff offering continuity of intervention delivery tailored to individual patient need were 
identified as important for patient engagement with telehealth; this was not delivered consistently, 
particularly in the early stages of the trials. Finally there was a lack of active engagement from 
primary care. 
Conclusions:  The conceptual model was supported and could be used to develop further telehealth 
interventions for chronic conditions. It may be possible to increase the effectiveness of this, and 
similar interventions, by attending to the human as well as the technical aspects of telehealth: 
offering it to patients actively wanting the intervention, ensuring continuity of delivery by 
enthusiastic and motivated staff, and encouraging active engagement from primary care staff. 
Key words: telehealth, depression, cardiovascular diseases, qualitative research, chronic disease, 
randomized controlled trials, primary health care 
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Introduction 
The increasing prevalence of chronic conditions presents a challenge to health systems 
internationally in terms of the ability to meet patients’ healthcare needs. There is interest in the 
potential of technology to address this challenge by offering an alternative to face-to-face care 
between healthcare professionals and patients [1].  Telemedicine or telehealth delivers health care  
at a distance using information and communication technologies for diagnosis, treatment and 
prevention of health problems.[1] These technologies can be supported by different types of clinical 
and non-clinical staff and thus expand health care provision and increase access to care. Policy 
makers worldwide  have enrolled large numbers of patients in telehealth schemes [1-3], and are 
evaluating telehealth programmes [1, 4].   
Despite the promotion of telehealth internationally, evidence of benefit is mixed [5-7]. A large 
review of the effectiveness of telehealth for chronic conditions concluded that the evidence base is 
weak and inconclusive due to publication bias, short- term outcome measurement, and a lack of 
focus on cost-effectiveness [5]. A review of reviews of telehealth concluded that telehealth could be 
effective for the management of some chronic conditions but that evidence is mixed with a need for 
larger studies [6]. A more recent review of interactive telehealth concluded that telehealth was 
effective for some chronic conditions, specifically heart failure and diabetes, but that evidence was 
inconsistent for other conditions [7].  
The lack of consistency of the evidence base on telehealth could reflect a lack of theoretical 
underpinning for many interventions or problems with the quality of their evaluation. It has been 
recommended that large, rigorous evaluations of any new interventions are undertaken [8]. 
Furthermore, process evaluations undertaken alongside trials of complex interventions such as 
telehealth may enable researchers to understand why interventions succeed or fail by exploring 
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context, mechanisms of action, and implementation of the intervention [9]. Qualitative research can 
contribute to this [10]. 
Researchers have started to address the need for large, pragmatic trials of theory-based telehealth 
for chronic conditions. Two large, linked, randomised controlled trials of a telehealth intervention, 
known as the Healthlines Service, which followed up patients for a year, focused on depression and 
on risk factors for cardiovascular disease (CVD) [11]. The trial targeting depression identified a 
moderate clinical benefit [12], while the trial focusing on reducing risk factors for CVD identified a 
partial effect; that is, improvement in some individual risk factors but not overall CVD risk score [13]. 
An embedded qualitative study was undertaken with both of these trials with the aim of explaining 
the results of the trials ..[11]. In this paper, we report this embedded qualitative study to explore 
why the trials showed modest effects only, and then discuss the implications of this for future use 
and evaluation of this type of telehealth intervention.  
Methods 
 
The telehealth intervention is described in Figure 1.  The two randomised controlled trials are 
described in Figure 2.   
Figure 1 The intervention  
The content and delivery of the Healthlines Service was underpinned by a conceptual model called 
the TElehealth in CHronic disease (TECH) model [14]. This model was constructed by the research 
team based on an extensive review of quantitative and qualitative evidence, a qualitative interview 
study with patients and staff experienced with telehealth or with chronic conditions [15], and a 
postal survey of patients’ levels of interest in different forms of telehealth [16]. The TElehealth in 
CHronic disease model builds on the Chronic Care Model [17] and proposes that telehealth 
interventions are most likely to be effective and acceptable if they address: (i) engagement of 
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patients and health professionals; (ii) effective chronic disease management (including self-
management, optimisation of treatment, care co-ordination); (iii) partnership between providers; 
and (iv) patient and health system context. This model was used to design a telehealth intervention 
for two exemplar chronic conditions: depression and raised CVD risk. 
The Healthlines Service was based on regular telephone calls over a 12-month period from a non-
clinical Health Information Advisor. The content of the calls was guided by scripts within computer 
software designed for the study. The Health Information Advisors also used motivational 
interviewing skills to encourage behaviour change and improve self-management. Patients were 
encouraged to identify goals, and then offered links to information about quality-assessed resources 
on the Internet. Some aspects of the intervention were condition-specific. For patients with 
depression, the intervention included book-based or computerised cognitive behavioural therapy 
and access to an online mental health network (Big White Wall). For patients with raised CVD risk, 
the intervention included blood pressure self-monitoring using loaned blood pressure monitors with 
automated feedback via a web portal and advice about diet, exercise and smoking cessation. For 
both conditions, patients’ use of medication was reviewed by the Health Information Advisor. 
Problems with medication adherence were addressed; where patients were not being treated in 
accordance with national guidelines, a treatment recommendation was sent to their GP and copied 
to the web portal where the patient could view it. The intervention was designed to complement 
primary care delivered in general practice. The intervention was delivered by NHS Direct which was a 
national telephone-based service at the time of the study. The staff members delivering the 
intervention were experienced Health Information Advisor s who were given additional training to 
deliver the Healthlines Service. 
 
Figure 2 The trials 
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The Healthlines Service was tested in two linked, pragmatic randomised controlled trials comparing 
the intervention plus usual care versus usual care alone. Usual care for depression was attendance 
at general practice, including use of medication and possible referral to psychological services.  Usual 
care for raised CVD risk was attendance at general practice where patients might receive blood 
pressure monitoring, medication and lifestyle advice. The trials were undertaken with adults with 
depression or raised CVD risk recruited from 43 general practices in three areas of England. Both 
trials were powered to detect odds ratios of 1.7 with 80% power [11]. In total, 609 patients were 
recruited to the depression trial. The primary outcome was response to treatment measured using 
the Patient Health Questionnaire (PHQ-9) [18] and defined as a reduction ≥ 5 points and score < 10 
after four months. The treatment response was higher in the intervention group than the control 
group (27% v 19%, odds ratio=1.7 (95% confidence interval (CI) 1.1, 2.5; p=0.02)). Twenty-five 
percent received little or none of the intervention [12], which is a similar rate to other pragmatic 
trials of telehealth for depression. 
Overall, 641 people were recruited to the CVD risk trial. The primary outcome was response to 
treatment defined as maintenance/reduction in 10-year risk of CVD (measured by QRISK2 score [19]) 
after 12 months. Participants receiving the intervention had a modest response to treatment 
compared to usual care (50% versus 43% respectively; adjusted odds ratio 1.3; 95% CI 1.0 to 1.9). 
The intervention was associated with reductions in blood pressure (difference in mean systolic -2.7 
mmHg (95% CI -4.7 to -0.6)) and weight (-1.0 kg (95% CI -1.8 to -0.3)), but not in cholesterol or 
smoking status. Eight percent of intervention participants received little or none of the intervention, 
and a third received the full course of intended telephone encounters over the course of a year [13].  
 
We undertook a qualitative interview study alongside the two trials to explain the results of the 
trials. We planned to interview three groups who could reflect on the intervention: primary care 
staff working in collaboration with the intervention who could offer perspectives on its feasibility 
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and acceptability to primary care; staff from the organisation delivering the intervention (NHS 
Direct) who could offer perspectives on feasibility; and patients who had experienced the 
intervention who could reflect on its acceptability. We chose to use the data collection method of 
interviews because they allow in-depth exploration of individuals’ perceptions.  
Sampling 
For the first group (primary care staff), we planned to sample six general practices, selected to 
include practices with populations from varying levels of deprivation. We had to widen our original 
sample from six to 13 general practices because it proved difficult to recruit sufficient numbers of 
primary care staff from the original set of practices. Within the 13 practices, we sampled purposively 
to reflect the range of relevant professionals offering primary health care to participants within the 
intervention arm of the trial: GPs and practice nurses or health care assistants.  
For the second group (NHS Direct staff), we sampled staff purposively to include those delivering the 
intervention to participants (Health Information Advisor s), those offering technical expertise for the 
intervention, and those involved in team and strategic management.  
For the third group (patients), we first sampled patients purposively from the intervention arm of 
the trials to ensure half of interviewees were in the depression trial and half in the CVD risk trial. 
Next, we used maximum variation sampling so that patients were interviewed who differed in terms 
of gender, age, and levels of depression or types of CVD risk factors. Because a large proportion of 
patients using the intervention for depression used little or none of the intervention (25% in 
depression trial vs. 8% in CVD risk trial), we also interviewed some patients who had withdrawn from 
the depression intervention. 
Data collection  
For primary care staff, we wrote to GPs and practice nurses in participating practices asking for 
consent for an interview. We interviewed primary care staff at different stages of the trial period to 
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obtain a mix of views at an early and later stage of the intervention delivery. Interviews took place 
face-to-face at their workplace or by telephone if this was more convenient. 
For NHS Direct staff, we approached senior managers in order to identify relevant staff. We 
interviewed staff in July 2013, around 12 months after the first depression participant was 
randomised and eight months after the first CVD risk participant was randomised. This allowed staff 
to reflect on both the early and later stages of intervention delivery. 
For patients, we contacted those recruited to the intervention arm of the trials who had consented 
to participate in the interview study during the trial recruitment process. We interviewed these 
patients after at least four months (depression) or six months (CVD risk) of experiencing the 
intervention to allow us to obtain reflections on different stages of their care. This was after the 
primary outcome measure had been collected in the depression trial (four months) and after the 
first collection of follow-up outcome data (at six months) in the CVD risk trial. Patients who had 
withdrawn from the intervention were interviewed within five months of recruitment. Face-to-face 
interviews with patients took place at their home or an alternative venue, depending on their 
preference.  
SJD undertook most of the interviews, with support from AF and KH. We obtained written informed 
consent from all interviewees. Regardless of interviewee type, the focus of the interviews was on 
the intervention. We asked about its perceived utility, problems arising, and issues that enhanced or 
hindered its operation in practice. In addition, we asked about the components of the conceptual 
model underlying the intervention: engagement, promoting self-management, treatment 
optimisation, care coordination, partnership, and context. Interviews lasted on average 45 minutes 
for staff, ranging from 16 to 88 minutes, and 58 minutes for patients, ranging from 21 to 124 
minutes. 
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Analysis 
Interviews were digitally recorded and transcribed verbatim. The Framework approach was used to 
analyse the data [20]. We read some transcripts from each type of interviewee for familiarisation 
(stage 1 of framework analysis). We constructed a thematic framework based on reading these 
transcripts and the functions of context, mechanisms of action and implementation important to 
process evaluations [9] (stage 2 of framework analysis). Since this qualitative study was embedded 
within randomised controlled trials, we supplemented this approach with a framework of the use of 
qualitative research with trials [10]. This permitted further exploration of themes concerning the 
trial, outcomes and the health conditions under study. Sub-themes of the theme ‘mechanisms of 
action’ were informed by the components of the TElehealth in CHronic disease model: engagement, 
promoting self-management, treatment optimisation, care coordination, partnership, and context 
[14].  
SJD coded all transcripts to the thematic framework, adding emerging sub-themes throughout this 
process (stage 3 of framework analysis). SJD, AOC, AF and KH then read the text within each sub-
theme, paying attention to which interviewees contributed to each sub-theme. The final stage of the 
framework approach – ‘mapping and interpretation’ – involved consideration of relationships 
between themes and sub-themes. As recommended, the analysis was undertaken prior to any team 
member knowing the outcomes of the trials [21]. Findings of the qualitative study were discussed 
amongst the research team in September 2014 before the trial results were known. We suggested in 
our conclusions from this analysis that the intervention would be effective because there was 
evidence within our data that components of the conceptual model helped some patients in both 
trials, and the intervention was implemented largely as planned. We also suggested that the 
complexity of patients’ lives and how the intervention was implemented appeared to diminish its 
impact. Paying attention to the balance of issues, we predicted a small to moderate benefit for each 
trial. In a second stage of analysis, after the trial outcomes were known in December 2014, we used 
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the findings of this qualitative work to help explain the results of the trials. This involved focusing on 
the themes we considered to be most relevant to the research question of why this intervention had 
produced a modest effect, whilst taking care to acknowledge the uncertainties around our 
explanation.  
The trials and qualitative study were approved by the National Research Ethics Service Committee 
South West–Frenchay (Reference 12/SW/0009), and had the following trial registrations: 
ISRCTN14172341 (Depression) and ISRCTN27508731 (CVD risk). 
 
Results 
Description of participants 
We undertook 45 interviews in total, with 21 staff and 24 patients.  
Staff 
We interviewed six GPs, five practice nurses, one healthcare assistant and one practice-based 
research nurse (13 in total) from 13 of the general practices that had participated in the trials. We 
approached practice staff who had been involved to some extent in the trials, for example, GPs who 
had screened lists of potential trial participants prior to recruitment.  From a total of 24 primary care 
staff approached for interview, seven GPs and four practice nurses declined, primarily because they 
did not feel they had anything to say about the intervention. 
We interviewed eight staff from NHS Direct. This included four Health Information Advisors  who had 
delivered the intervention for varying lengths of time. Two had worked in the Healthlines Service 
from the beginning, one for a few months and one had been in post for a month at the time of the 
interview. We also interviewed a strategic manager who had been involved in leading the 
intervention development, a technical manager who had helped to develop the intervention, a 
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supervisor of the HIAs and a team manager from the wider organisation who was not directly 
involved with the intervention but who managed the Health Information Advisors  as part of larger 
team. This latter interview was undertaken to explore the wider organisational context in which the 
intervention was delivered.  
Patients 
We approached 16 depression and 20 CVD risk trial participants to obtain 12 interviews with each 
group. Patients declined to participate because they said they were not interested (n = 6), were too 
busy (n = 3), could not be contacted (n = 1), or did not attend the arranged interview (n = 2). 
Interviewees participating in the depression trial were interviewed a median of eight months after 
randomisation, varying between five and 10 months. There were seven females, they were all white, 
and mainly middle-aged (age range 30-66). This generally reflected the demographics of participants 
in the depression trial. According to the baseline PHQ-9 classifications, one interviewee had severe 
depression, four interviewees had moderately severe depression and the remainder had moderate 
depression. Four interviewees had formally withdrawn from using the intervention at the time of the 
interview.  
CVD risk interviewees were interviewed a median of eight months after randomisation, varying 
between three and 11 months. They were mainly male (n = 9), all white, and all older (age range 62-
75). This demographic mix was largely in line with the participants in the CVD risk trial. They had a 
mix of CVD risk factors at baseline: two smoked, nine had a body mass index (BMI) >=30 and eight 
had systolic blood pressure >=140. Eight were on blood pressure lowering medication. The CVD risk 
score (QRISK2) was high for all interviewees (as that was an inclusion criteria for the trial), ranging 
between 21% and 58%; three had a score higher than 45%. None of the interviewees had formally 
withdrawn from using the intervention at the time of the interview.  
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Overview of findings 
The findings are presented using the framework of mechanisms of action, context and 
implementation. We show that interviewees perceived that the intervention was useful for some 
patients  and described aspects of the intervention that they valued. However, contextual issues and 
problems with implementation negatively affected the impact of the intervention. Quotes are 
accompanied by labels showing the type of staff or characteristics of patients.  
Mechanisms of action 
Perceptions that the  intervention was useful for some patients 
Interviewees perceived that the intervention had improved the health of some patients. First, 
staff delivering the intervention described individual patients reporting improved mood and 
weight loss. They did not describe the characteristics of these patients, but, instead, described 
the characteristics of patients who they perceived were not being helped by the intervention 
(see next section). Second, some of the patients interviewed reported improvements in health 
which they associated with the intervention. Amongst the patients in the depression trial, six 
described benefits such as feeling more positive because they had been shown ways to cope, 
had learned to share problems with their family, felt listened to, or felt that someone cared 
about them:  
“what I needed was a way of dealing with the great sadnesses and a way of coming to terms 
with it, and I think I’ve got that from [pause], from The Healthlines Study” (Dep 8, female, 
aged 66, with moderate depression at baseline) 
Nine of the twelve CVD risk interviewees had a BMI of 30 or over at baseline. Three of these 
reported weight loss which they attributed to the intervention. They were delighted with the 
amount of weight they had lost since joining the study and described other positive consequences, 
including reduced blood pressure, ability to walk more easily, and having more energy. Some CVD 
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risk interviewees reported making lifestyle changes that could affect CVD risk factors, such as 
exercising more, eating more healthily and reducing alcohol intake. Four of the eight interviewees 
with high blood pressure at baseline (systolic above 140) reported lowered blood pressure and 
another reported reduced use of blood pressure medication related to the intervention. 
Improvements in blood pressure were attributed to weight loss or introduction of blood pressure 
medication: 
“Interviewer: You’ve got high blood pressure I’m presuming? 
CVD participant: Not anymore. 
Interviewer: Not anymore, good [laugh] 
CVD participant: Mainly thanks to this system” (CVD risk 8, male, aged 70, with 
high blood pressure at baseline) 
Aspects of the intervention valued by staff and patients 
When asked about the different components of the intervention, interviewees tended to describe 
their value and how they helped to improve health. That is, there was support for the conceptual 
model upon which the intervention was based. For example, both the Health Information Advisors 
delivering the intervention and patients receiving it described the necessity and value of different 
aspects of the intervention aimed at encouraging patient engagement. This included the technical 
support for patients which helped them to use computer-based aspects of the intervention, the 
continuity of contact with the same Health Information Advisor which helped to build rapport with 
patients, and enthusiastic and motivated Health Information Advisors who made the effort to tailor 
the intervention to patients’ needs:  
“it has been good to build up some kind of relationship” (CVD risk 11, female, aged 49, 
overweight at baseline) 
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There was also support for the value of the self-management aspect of the intervention. Most of the 
patients we interviewed described how the intervention helped them to develop self-management 
skills through raising awareness of their health problems and educating them about ways of dealing 
with those problems. As one patient put it, the intervention was about “helping myself to help 
myself” (Dep 2, male, aged 60, with moderately severe depression at baseline).  
 “I think it makes people realise that there are things that you can do on a day to day basis 
[…] to bring [their blood pressure] down, if they’re checking it that regularly for a purpose. 
You know, I went out for a walk this morning and my blood pressure was really good today, 
and things like that. It makes it very obvious in black and white right in front of them that the 
days when they are doing things, and being a bit more well-behaved if you like, that it does 
make a difference.” (Practice Nurse 113)  
“and then it just gives them something to work on and I make it clear to them all that they 
have to do the hard work themselves if they want to reach their target. And 8 times out of 10 
next time I speak to them they’ve done it or the first thing they say to me is ‘well I’ve been 
eating off a smaller plate’ and it’s really nice to hear that.” (Health Information Advisor  2) 
Finally, there was some evidence of medication optimisation occurring. Some patients receiving the 
depression intervention were on antidepressants, and some CVD risk participants were on blood 
pressure medication and statins. Interviewees reported that the intervention impacted on 
medication taking through Health Information Advisors prompting patients to discuss medication 
with their GP, or through letters directly from Health Information Advisor s to GPs.  
Context  
Individual context: lack of fit with perceived need  
A key contextual issue, which may have impacted on the effectiveness of the intervention, was 
patients’ desire to improve their health. Patients with depression and primary care staff reported 
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long waits for access to usual care services such as counselling and cognitive behavioural therapy. 
Patients with CVD risk factors wanted to improve their health, and some of those who wanted to 
improve their lifestyle perceived a lack of advice about how to do this, even though the practice 
nurses we interviewed said they offered this service. 
 However, there were indications that some patients did not understand what the intervention 
entailed when they signed up to join the trial and, in fact, had no interest in what was on offer once 
they had started the intervention. Some patients in the depression trial described the intervention 
as too superficial, not giving access to a therapist, or the same as previous treatments because they 
had already tried cognitive behavioural therapy.  
Some patients in the CVD risk trial reported low motivation to change their lifestyle; they had been 
interested generally in improving their health without necessarily understanding that this would 
entail them making lifestyle changes, or had joined the study for altruistic reasons in terms of 
helping others through participating in research: 
“and, I thought, well it’ll help me, but it might help somebody else, that’s the reason I had a 
go” (CVD risk 7, male, aged 74, with high blood pressure at baseline) 
Other patients in the CVD risk trial had no intention of addressing a key CVD risk factor that led to 
their eligibility for the trial. In particular, two of our CVD risk interviewees were smokers at baseline. 
Both of these reported no success with smoking cessation because they did not want to stop 
smoking: “don’t bother, I smoke” (CVD risk 1, male, aged 62, smoker with high blood pressure at 
baseline). Health Information Advisors noted that few patients had reported giving up or cutting 
down smoking and that this was a difficult lifestyle issue to have an impact upon. The staff we 
interviewed believed that if intrinsic motivation to change was absent, then patients, particularly 
those in the CVD risk trial, would find it difficult to make the necessary lifestyle changes in the 
timeframe in which the intervention was offered.  
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Individual context: lack of fit with patients’ lives  
Patients in the depression trial tended to be of working age whereas those in the CVD risk trial 
tended to be retired. These younger patients with depression were described by Health Information 
Advisors as too busy due to child care and employment to engage with key aspects of the 
intervention such as the telephone calls and homework for the cognitive behavioural therapy. The 
Health Information Advisors wondered whether lack of engagement was due to their depression as 
well as their busy lives. They felt that those who did complete the cognitive behavioural therapy 
course obtained benefit from it, and so they wanted the inclusion criteria for the trial to focus on 
those who were really committed to making changes and engaging with the intervention:  
“The depression ones, a large, it seems to be a lot, to me, younger people, a lot more women, 
not all but they’re rushing around, they don’t have time, they forget they’ve got 
appointments, and whether it’s part of depression or not I don’t know, but they don’t often, 
they don’t answer the phone” (Health Information Advisor  1) 
Some interviewees from the depression trial described serious ongoing life events such as the threat 
of losing disability and unemployment benefits, physical illnesses, or coping with family members 
and friends who were very ill or depressed. These issues caused stress on top of the depression, 
making engagement with the intervention difficult. According to the Health Information Advisors in 
our study, life events preventing engagement with the intervention appeared to be less of an issue 
for CVD risk patients. Our interviewees with CVD risk factors did not offer the same description of 
complex lives as our interviewees with depression. The level of complexity of patients’ lives may 
have been related to age because the patients in the CVD risk trial were older and many were 
retired. Only one of the CVD risk interviewees was still in full-time paid employment, and this 
interviewee did report finding it difficult to fit the intervention into their life.  
Research context: a randomised controlled trial   
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The intervention was offered in the context of a randomised controlled trial. The intervention for 
depression was ready for use at the beginning of the trial and needed little or no adaptation during 
the trial. However, interviewees from NHS Direct discussed delays in starting the CVD risk 
intervention at the beginning of the trial due to a number of technical problems with the 
intervention. This resulted in some patients waiting for several months between randomisation and 
receiving the intervention. As specified in the trial protocol, the primary outcome of the CVD risk 
trial was measured 12 months after randomisation. This resulted in measurement of 12-month 
outcomes before some patients had completed the intervention, which may have reduced the 
measured effect of the intervention for CVD risk.  
Implementation of the intervention 
When we asked the three groups of interviewees about different components of the intervention, 
they not only described the value of these components (see earlier), but also described how they 
occurred in practice. With the exception of three issues (described below), their descriptions aligned 
with the planned implementation of the Healthlines Service.  
Continuity of enthusiastic and motivated Health Information Advisors  
Continuity of care - ensuring the same Health Information Advisors talked to the same patient 
throughout their care – was one of the ways in which the intervention delivered the patient 
engagement component of the TElehealth in CHronic disease  conceptual model.  This appeared to 
be very important to some patients we interviewed and was compromised in the early months of 
implementation. Interviewees from NHS Direct described how, during the earlier months of the 
intervention, they tested out a model of using staff part-time in the Healthlines Service and part-
time in the wider organisation. This made it difficult for the same Health Information Advisor  to 
contact the same patients and also caused challenges for Health Information Advisors trying to learn 
to use a technically complex intervention. It was also compounded by large numbers of patients 
19 
 
entering the CVD risk at the same time. This lack of continuity compromised the ability of Health 
Information Advisors to actively tailor the intervention to different patients. As the intervention 
progressed, NHS Direct changed the model of provision to a small dedicated team of staff who were 
enthusiastic about the intervention and felt motivated to help patients to improve their health. The 
Health Information Advisors we interviewed were part of this dedicated team and described how 
they placed emphasis on providing continuity of care and tailoring the intervention to the needs of 
individual patients. However they also described how continuity of care could not be fully delivered 
even in the later stages because the small team sometimes struggled to cover sickness absence and 
holidays whilst still providing appointments which suited patients.  
The variation in implementation was evident in patients’ descriptions of their experiences. Some of 
the patients we interviewed appreciated the relationship they had built up with an Health 
Information Advisor , feeling listened to and cared for. Others described Health Information Advisors 
as ‘going through the motions’, rather than attempting to tailor the intervention: ‘because the spiel 
was exactly the same’ (CVD risk 10, male, aged 71, with high blood pressure at baseline). This latter 
group struggled to engage with the intervention. Indeed three of the interviewees in the depression 
trial who expressed concern about a protocolised approach had withdrawn from the intervention.  
Modification of intervention delivery during the trial 
NHS Direct staff described how continuing technical difficulties had to be sorted out during the early 
weeks of using the intervention for CVD risk. Health Information Advisors explained how they had to 
learn to make the software work in the context of an ongoing conversation with a patient, modifying 
the flow of the scripts that were built into the intervention to reduce repetition for patients. They 
also described how they made notes about patients outside the computerised system to help them 
set and monitor plans for patients.  
Collaboration with primary care 
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The primary care staff we interviewed had little to say about specific aspects of the intervention. 
Health Information Advisors and patients described how GPs responded to prompts to consult with 
patients or change medication, but also described how they did not take an interest in patients’ 
experiences of the intervention or proactively contact the Healthlines Service about individual 
patients. There was also some evidence that communication between primary care and Health 
Information Advisors did not always reach the level of partnership intended by the conceptual 
model, which could cause confusion for some patients. For example, GPs did not necessarily agree 
with advice from the intervention, which was based on national guidelines:   
“there was this one particular patient who was constantly being, it was being suggested that 
he be reviewed by the GP. And the GP was reviewing him, but it was still the same, you know, 
it was a bit, you know, flogging a  bit of a dead horse really, because she was, the GP was 
very happy with the blood pressure. Healthlines Study staff were saying, oh, no, no, no you 
need to go and see the GP […] and of course the patient is the one caught in the middle ” 
(Practice Nurse 111) 
 
Discussion 
 
Principal results 
The interviewees described improved outcomes in some patients receiving the intervention. They 
attributed these improvements to the intervention, describing how components of the conceptual 
model on which the intervention was based helped to achieve benefit. Aspects of the intervention 
addressing patient engagement, self-management and medication optimisation were valued. 
Implementation of the intervention occurred largely as planned. However, problems related to 
context and implementation may have reduced the size of effect. For depression, the context of 
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patients’ lives was often complex, resulting in these working-age patients sometimes being unable to 
engage with the intervention. Some patients also wanted a more therapist-based approach rather 
than the cognitive behavioural therapy on offer. For CVD risk, contextual issues included some 
patients joining the trial in the hope of improving their health generally, or altruistically helping with 
research, rather than being motivated to make lifestyle changes to address their specific risk factors. 
In addition, implementation was not optimal in the early part of the CVD risk trial as technical 
difficulties with the intervention were addressed and staff delivering the intervention adapted it for 
use in practice. For both conditions, enthusiastic and motivated staff members offering continuity of 
intervention delivery tailored to individual patients’ needs were identified as important for patient 
engagement with telehealth, but this was not delivered consistently, particularly in the early stages 
of the trials. Finally there was a lack of active engagement with the intervention from general 
practitioners in primary care. Although some of these issues related to the technological aspects of 
the intervention, most related to human issues - the complexity of patients’ lives and the need for 
skilful human support to complement the technology. 
Strengths and limitations 
One key strength of this qualitative study was the inclusion of interviews with a wide range of 
stakeholders: staff offering primary care to patients, managers and frontline staff delivering the 
intervention, and patients who had used the intervention and those who had withdrawn from it. 
This greatly improved our understanding of the trial results and provided support for the use of the 
TECH conceptual model to underpin these kinds of interventions. There were four limitations. First, 
we could have used non-participant observation in combination with the interviews, such as 
listening to telephone calls and observing Health Information Advisors in their daily work, which may 
have helped to further understand implementation of the intervention. Second, although we felt 
that we achieved data saturation at the data collection stage for most of the groups we targeted, 
this was not the case for participants in the CVD risk trial because of the range of risk factors they 
had. Third, inclusion of other groups may have helped to further understand the intervention; in 
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particular, Health Information Advisors who had left the service and patients in the control arm of 
the trials. Finally, we completed our data collection before the end of the intervention. The 
organisational context in which the intervention was delivered changed towards the end of 
intervention delivery. NHS Direct ceased to operate towards the end of the trials, although the 
intervention continued to be offered by the same Health Information Advisors working for a 
different organisation. During the change in the organisation hosting the service, there was a pause 
in service delivery for some patients and this might have affected their engagement with the 
intervention. However we did not have data from those delivering or receiving the intervention 
during or after this change. 
Comparison with prior work 
Some patients in the trials did not engage with the intervention: 25% of patients in the depression 
trial and 8% of patients in the CVD risk trial used little or none of the intervention [12,13]. These 
rates were smaller than a trial of a web based program for reducing CVD risk where almost half of 
the intervention users had dropped out at 12 months [22].  Interestingly the qualitative research 
undertaken alongside that trial recommended the addition of human interaction to motivate and 
engage patients. Our qualitative study identified that motivated staff could enhance patient 
engagement and that engagement was also dependent on human factors related to the patients. It 
identified that patients wanted help with their health, but not necessarily the intervention on offer, 
or did not see the intervention as a priority in their complex or busy lives. This finding is similar to a 
systematic review of computerised cognitive behavioural therapy – a core component of our 
intervention for depression - which identified that a median of 56% participants completed a full 
course and that personal circumstance was more commonly cited as the cause for non-completion 
than difficulties with the technology or social background [23]. We know that a large proportion 
(82%) of invited patients chose not to participate in our trials in the first place [24]. Amongst those 
actively declining participation (rather than not replying to the trial invite), common reasons given 
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were that they were too busy or they were not interested in the research. It was also the case that 
some patients agreed to participate who did not want the intervention on offer or whose lives were 
too complex to make use of it. Although efforts were made to communicate to potential participants 
in advance about what the intervention entailed, it is possible that the nature of the intervention 
was not described clearly enough and was misunderstood, or that participants held expectations of 
the intervention that differed from their experience. These patients might have declined to take part 
in the trial if they had known more about the content of the intervention and the efforts required of 
them.  
Researchers are beginning to test ways of increasing the acceptance of internet-based mental health 
interventions using an informational video[25]. This type of video may also be useful when recruiting 
patients for trials of telehealth interventions to help them make informed choices about 
participation. For example, people who smoke and do not want to stop might decline to participate 
if they understand that a key focus on the intervention is to help them reduce this risk factor. This 
may reflect the real world more because, in practice, patients tend to access smoking cessation 
services if motivated to stop smoking. It is possible that a future trial with more emphasis on 
communicating the content of the intervention, and the efforts required by patients to obtain 
benefit, might result in larger effect sizes than seen here.  
The importance of the human aspect of telehealth, in terms of who delivers the intervention and 
how, was evident from these interviews. This ‘personal context’ of factors, related to the 
practitioners involved, in terms of their perceptions of the relevance of and interest in the 
intervention, their skills, and their motivation has been identified as a type of context affecting how 
interventions work [26]. In our study this personal context of motivated Health Information Advisors 
appeared to facilitate patient engagement with the intervention through both developing rapport 
and tailoring the intervention. These two issues have been identified as mechanisms of action of 
telehealth for chronic conditions.[27] Other researchers have also identified the importance of 
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continuity of the person delivering telehealth, and their level of motivation during delivery [23, 28-
30]. This has also been identified as important for the self-management of chronic conditions more 
generally. For example, a recent systematic review of interventions for the self-management of 
asthma identified the importance of actively engaging patients and having motivated professionals 
delivering interventions [31]. This focus on the importance of motivated humans delivering 
telehealth has not been identified consistently. For example qualitative research alongside an RCT of 
an educational web-based tool to prevent problems in young people whose parents had mental 
health problems identified technical problems as the key barrier [32]. 
The lack of proactive engagement with the intervention from primary care was perhaps not too 
surprising given earlier interviews with practice nurses and general practitioners prior to developing 
the intervention [15]. These health professionals were ambivalent and often sceptical about the 
contribution of telehealth to the care of chronic conditions. The conclusion of this earlier research 
was that there was work to be done in terms of helping primary care health professionals to 
understand the changes in roles and new ways of working necessary to facilitate the introduction 
and integration of telehealth innovations into their services. Our conclusions post-delivery of the 
intervention were similar, in that there is a need to develop better strategies for primary care 
engagement with telehealth. This lack of primary care engagement with interventions aimed at 
chronic conditions is not specific to telehealth interventions [33].  
Implications 
When delivering this or similar interventions in the real world, service providers may wish to 
consider communicating the content of the intervention clearly to prospective users, and the 
amount of time and effort required by them to obtain benefit. They may also wish to ensure the 
service is provided by motivated staff who can offer continuity of care and tailor the intervention to 
patients’ needs. Given the lack of engagement from primary care, it may also be helpful  for future 
interventions to try to develop better strategies for primary care engagement that also take into 
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consideration the heavy workload in general practice in the UK currently. These actions may increase 
the effect of this or similar interventions in the future. There are also implications for the treatment 
of other chronic conditions. The conceptual model for the intervention was supported by this 
qualitative research, and so could be used to develop further interventions tailored for different 
conditions. These interventions would have to undergo rigorous evaluation in randomised controlled 
trials. Finally, there is a methodological implication for triallists. Because of technical problems and 
delays, some aspects of the intervention were not fully functional during the early months of the 
trials, particularly for CVD risk. The possible implications of this are that participants in the early 
stage of the trials may have received an under-developed intervention. Feasibility testing prior to a 
full evaluation is an important aspect of the evaluation of complex interventions [34], although 
finding sufficient resources to do so within a fixed research timeline and budget when the problems 
cannot necessarily be anticipated in advance may be challenging. 
Conclusions 
This qualitative research helped to explain why the outcomes of two linked trials were modest. The 
conceptual model of the intervention was supported and could be used to develop further 
telehealth interventions for chronic conditions. It may be possible to increase the effectiveness of 
this, and similar interventions, by attending to the human as well as the technical aspects of 
telehealth: offering it to patients actively wanting the intervention, ensuring continuity of delivery by 
enthusiastic and motivated staff, and encouraging active engagement from primary care. 
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